Skip to main content
SpringerLink
Log in

Kardiale Resynchronisationstherapie bei Hochrisikopatienten mit Herzinsuffizienz der NYHA-Stadien I–II

Cardiac resynchronization therapy for high risk patients with NYHA stages I–II cardiac insufficiency

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Abraham WT, Fisher WG, Smith AL et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853

    Article  PubMed  Google Scholar 

  2. Auricchio A, Fantoni C, Regoli F et al (2004) Characterization of left ventricular activation in patients with heart failure and left bundle-branch block. Circulation 109:1133–1139

    Article  PubMed  Google Scholar 

  3. Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150

    Article  CAS  PubMed  Google Scholar 

  4. Cazeau S, Leclerq C, Lavergne T et al (2001) Multisite stimulation in cardiomyopathies (MUSTIC) study investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880

    Article  CAS  PubMed  Google Scholar 

  5. Cleland JG, Daubert JC, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549

    Article  CAS  PubMed  Google Scholar 

  6. Epstein AE, DiMarco JP, Ellenbogen KA et al (2009) ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guidelines update for implantation of cardiac pacemakers and antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117(21):e350–e408

    Google Scholar 

  7. Ghandari H, Dalloul G, Hasan R et al (2009) Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure. Arch Intern Med 169:1500–1506

    Article  Google Scholar 

  8. Goldenberg I, Moss AJ, Hall WJ et al (2006) Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Defibrillator Implantation Trial II. Circulation 113:2810–2817

    Article  PubMed  Google Scholar 

  9. Jung W, Andresen D, Block M et al (2005) Leitlinien zur Implantation von Defibrillatoren. Clin Res Cardiol 95:696–708

    Article  Google Scholar 

  10. Linde C, Abraham WT, Gold MR et al (2008) Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 52:1834–1843

    Article  PubMed  Google Scholar 

  11. Moss AJ, Hall WJ, Cannom DS et al (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–1940

    Article  CAS  PubMed  Google Scholar 

  12. Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    Article  PubMed  Google Scholar 

  13. Moss AJ, Hall WJ, Cannom DS et al for the MADIT-CRT Trial Investigators (2009) Cardiac-resynchronisation therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338

    Article  PubMed  Google Scholar 

  14. Saxon LA, Hayes DL, Day J et al (2009) Survival after ICD and CRT-D implant in a large cohort of heart failure patients treated with contemporary drug and device therapies – results of the ALTITUDE study. Scientific Sessions American College of Cardiology

  15. Tang AS, Wells GA, Arnold M et al (2009) Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design. Curr Opin Cardiol 24:1–8

    Article  CAS  PubMed  Google Scholar 

  16. Trappe HJ (2007) Plötzlicher Herztod. Häufigkeit, Risikoidentifikation, Behandlungsstrategien. Kardiologe 1:261–271

    Google Scholar 

  17. Trappe HJ (2008) Kardiale Resynchronisationstherapie. Voraussetzungen, Ergebnisse, Perspektiven. Kardiologe 2:407–416

    Article  Google Scholar 

  18. Trappe HJ (2009) 25 Jahre Defibrillatortherapie in Deutschland. Was haben wir erreicht, was können wir noch erwarten? Kardiologe 3:413–424

    Article  Google Scholar 

  19. Vardas PE, Auricchio A, Blanc JJ et al (2007) Guidelines for cardiac pacing and cardiac resynchronization therapy. Eur Heart J 28:2256–2295

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Medizinische Klinik II (Schwerpunkte Kardiologie und Angiologie), Ruhr-Universität Bochum, Hölkeskampring 40, 44625, Herne, Deutschland

    H.-J. Trappe

Authors
  1. H.-J. Trappe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H.-J. Trappe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trappe, HJ. Kardiale Resynchronisationstherapie bei Hochrisikopatienten mit Herzinsuffizienz der NYHA-Stadien I–II. Kardiologe 4, 23–26 (2010). https://doi.org/10.1007/s12181-009-0237-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-009-0237-7

Search

Navigation